Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

689
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
689
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

1.3K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.3K
Hypertension I: Introduction01:28

Hypertension I: Introduction

1.1K
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
1.1K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

4.6K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.6K
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

573
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
573
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

797
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
797

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neuroprotective Effects of Ethiopian Coffee Beans against Hyperglycemia-induced Brain Injury in Rats.

Food science & nutrition·2026
Same author

Determinants of Healthcare-Seeking Preferences of Female Sex Workers: A Cross-Sectional Study From the South-Western Region of Bangladesh.

Health science reports·2026
Same author

GC-MS-Based Metabolomic Insights Into Fermentation-Induced Bioactive Compounds and Metabolic Health-Related Activities of White Corn Steep Liquor.

Food science & nutrition·2026
Same author

ProtAttn-QuadNet: An attention-based deep learning framework for protein-protein interaction prediction using ProtBERT embeddings.

PloS one·2026
Same author

Antidiabetic Evaluation of Thiosemicarbazone Analogs Through α-Amylase Inhibition Complemented With Computational Studies.

Chemistry & biodiversity·2026
Same author

Antidiabetic and Cytotoxicity Studies of Novel Quinazolinone-1,3,4-Thiadiazole Molecular Hybrids.

Chemistry & biodiversity·2026

Related Experiment Video

Updated: Mar 6, 2026

Assessing Murine Resistance Artery Function Using Pressure Myography
07:25

Assessing Murine Resistance Artery Function Using Pressure Myography

Published on: June 7, 2013

23.3K

Hypertension: From Basic Research to Clinical Practice.

Md Shahidul Islam1,2

  • 1Department of Clinical Science and Education, S-dersjukhuset. Karolinska Institutet. Research Center, 3rd floor, S-118 83, Stockholm, Sweden. Shahidul.Islam@ki.se.

Advances in Experimental Medicine and Biology
|March 16, 2017
PubMed
Summary

Hypertension, a major global health issue, significantly raises mortality risks and affects millions annually. The number of adults with high blood pressure has more than doubled globally since 1975, particularly in lower-income nations.

Keywords:
Books on hypertensionHypertension in high-income countriesHypertension in low-income countriesHypertension in middle-income countriesHypertension in the worldUpdate on hypertension

More Related Videos

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

8.1K
Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

1.3K

Related Experiment Videos

Last Updated: Mar 6, 2026

Assessing Murine Resistance Artery Function Using Pressure Myography
07:25

Assessing Murine Resistance Artery Function Using Pressure Myography

Published on: June 7, 2013

23.3K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

8.1K
Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

1.3K

Area of Science:

  • Cardiovascular Health
  • Public Health Epidemiology
  • Global Health Trends

Background:

  • Hypertension is a critical risk factor for end-organ damage, adverse maternal and fetal outcomes, and overall mortality.
  • Globally, hypertension contributes to approximately 7.5 million deaths each year.
  • The prevalence of hypertension has surged dramatically, with the number of affected adults worldwide increasing from 594 million in 1975 to over 1.1 billion by 2015.

Discussion:

  • The escalating rates of hypertension, especially in low- and middle-income countries, highlight a growing global health challenge.
  • Understanding the demographic and socioeconomic drivers of this increase is crucial for targeted public health interventions.
  • The long-term consequences of untreated or poorly managed hypertension pose a significant burden on healthcare systems and economies.

Key Insights:

  • Hypertension is a leading cause of preventable death and disability worldwide.
  • The dramatic rise in hypertension prevalence underscores the urgent need for global prevention and management strategies.
  • Low- and middle-income countries are disproportionately affected by the increasing burden of hypertension.

Outlook:

  • Future research should focus on effective, scalable interventions for hypertension prevention and control in diverse populations.
  • Continued global surveillance is essential to monitor trends and evaluate the impact of public health initiatives.
  • Addressing socioeconomic determinants of hypertension is key to mitigating its impact on global health and mortality.